← All trials
NCT06037980
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 7, 2023
- Primary completion
- Dec 31, 2028
- Completion date
- Jan 31, 2029
- First posted
- Sep 14, 2023
- Last posted
- Nov 15, 2023
- Enrollment
- 300
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Gruppo Oncologico del Nord-OvestLead sponsor
- University of MilanOverall official - principal investigator
- University of MilanOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.